Overheard at the J.P. Morgan Healthcare Conference
Executives detailed plans to take on more risk, build on advances in life sciences, and expressed optimism in Medicare Advantage, despite missing enrollment targets.
Drive Innovation
October 21, 2021
Taking Life Sciences ‘Beyond the Pill’
Life sciences companies need to be more engaged in building partnerships that promote high-value care.
Imagine a future where leveraging our DNA and what we know about it prevents illness and improves care outcomes.
And How Stakeholders Can, Literally, Save the World
Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.
New Predictions on COVID-19 Vaccines and Herd Immunity
How COVID-19 case counts and vaccines may get us back to normalcy by June.
In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.
A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.
2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.
Transform Care
December 18, 2018
Top 10 Oliver Wyman Health Articles of 2018
Our most popular articles of the year offered our predictions on disruption and the future market, and highlighted our views on healthcare reform, ACOs, and much more.